This change was correlated with reduction of CD8+ memory T cells and pro-inflammatory cytokine producing T cells (10) and has been associated to a low activity of the disease (12), probably related to a regulatory action on both innate and adaptive immune system of MS patients (22, 23). Here, CD8A is linked to myeloid sarcoma.